At this time, I would like to welcome everyone to the Veeva Systems fiscal 2025 fourth quarter and full-year results ...

Veeva Systems (NYSE:VEEV – Free Report) had its target price boosted by Morgan Stanley from $195.00 to $201.00 in a report ...

Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time ...

Additionally, it provides analytics through Veeva Crossix, customer data via Veeva OpenData, and real-time intelligence with Veeva Link. The company also supports clinical, regulatory, and safety ...

Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time ...

Veeva Systems (VEEV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

"Together with Veeva, Boehringer has advanced its approach to clinical trials and is fulfilling our pledge to accelerate the delivery of innovative, life-transforming treatments to patients across ...

Veeva disclaims any obligation to update or ... It's mostly driven by commercial and within commercial, it's Crossix. And that Crossix deceleration is mostly a function of last year's very strong ...